Gamco Investors INC. ET AL lessened its position in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 0.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,000 shares of the scientific and technical instruments company’s stock after selling 500 shares during the quarter. Gamco Investors INC. ET AL owned about 0.12% of Itron worth $6,080,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Hager Investment Management Services LLC acquired a new position in Itron during the 4th quarter valued at about $67,000. Contravisory Investment Management Inc. boosted its stake in Itron by 154.9% in the fourth quarter. Contravisory Investment Management Inc. now owns 864 shares of the scientific and technical instruments company’s stock valued at $94,000 after acquiring an additional 525 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in Itron by 347.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 886 shares of the scientific and technical instruments company’s stock worth $97,000 after acquiring an additional 688 shares during the period. GAMMA Investing LLC grew its holdings in Itron by 15.6% during the 4th quarter. GAMMA Investing LLC now owns 1,177 shares of the scientific and technical instruments company’s stock worth $128,000 after acquiring an additional 159 shares during the period. Finally, Steward Partners Investment Advisory LLC raised its position in shares of Itron by 43.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,820 shares of the scientific and technical instruments company’s stock valued at $198,000 after acquiring an additional 548 shares during the last quarter. Institutional investors own 96.19% of the company’s stock.
Insider Buying and Selling
In other news, CFO Joan S. Hooper sold 2,322 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $92.90, for a total value of $215,713.80. Following the completion of the sale, the chief financial officer now owns 92,076 shares of the company’s stock, valued at approximately $8,553,860.40. This represents a 2.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Christopher E. Ware sold 648 shares of the business’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $92.90, for a total transaction of $60,199.20. Following the transaction, the senior vice president now owns 20,326 shares in the company, valued at approximately $1,888,285.40. The trade was a 3.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,037 shares of company stock worth $385,815. 1.45% of the stock is owned by insiders.
Analyst Ratings Changes
Check Out Our Latest Analysis on Itron
Itron Trading Down 0.4 %
NASDAQ:ITRI opened at $101.65 on Thursday. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. Itron, Inc. has a twelve month low of $88.92 and a twelve month high of $124.90. The company has a market cap of $4.63 billion, a P/E ratio of 20.83, a price-to-earnings-growth ratio of 0.81 and a beta of 1.39. The business has a 50 day moving average price of $102.21 and a two-hundred day moving average price of $107.44.
About Itron
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories
- Five stocks we like better than Itron
- What is a Secondary Public Offering? What Investors Need to Know
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What is the FTSE 100 index?
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.